Tumor mutations may help predict relapse risk in childhood leukemia
Some cases of the most common childhood cancer, B-cell acute lymphoblastic leukemia (B-ALL), return after treatment - and genetic changes present from the start may help explain why.
Read original article on The Medical News →Related news
-
Key innate immune protein regulates cholesterol and influences cancer treatment resistance
United Kingdom
-
AI-powered heart MRI measurements better predict patients' survival
United Kingdom
-
AI improves accuracy and completeness of hospital discharge summaries
United Kingdom
-
Can Australia's social welfare system handle future aged care needs?
United Kingdom
-
Vitamin C supplements during pregnancy may support infant emotional health
United Kingdom
-
Toddler snacks pulled from Costco, Target, Walmart and other stores over choking danger
United Kingdom
-
Worldwide survey reveals declining mental well-being among young people
United Kingdom
-
Scientists estimate drownings cost the UK almost £1 billion a year
United Kingdom